http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110396102-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2019-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110396102-B |
| titleOfInvention | Cefoxitin sodium compound pharmaceutical preparation and application thereof in prevention of infection before vaginal hysterectomy, abdominal hysterectomy and cesarean section (uterine) |
| abstract | The invention provides cefoxitin sodium or a composition thereof, a preparation method, a single preparation, a compound preparation and application thereof. In the cefoxitin sodium or the composition thereof, the mass content of cefoxitin is more than 93 percent. The cefoxitin sodium or the composition thereof has low impurity content and good quality stability, and is beneficial to improving the clinical curative effect and safety; the particle size range is uniform, which is beneficial to reducing the process difficulty of preparation; the cefoxitin sodium or its composition, or its preparation can be used for preventing infection before or after transvaginal hysterectomy, abdominal hysterectomy, or cesarean section. |
| priorityDate | 2019-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 110.